Measuring the Financial Impact of California Stem Cell Spending: A Big Data Task
Neuro disease task force looking for metrics for billions in awards
What is the cure for what ails CIRM -- if anything does?
A health economics researcher is posing an answer or two and will lay them out before CIRM directors at a meeting tomorrow at 9 a.m.
Thirteen of the 35 directors of the state stem cell agency, officially known as the
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.